Clinical trial
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)
NCT03372161 is registered in ClinicalTrials.gov with Scilex Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)
- Lead sponsor
- Scilex Pharmaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 8, 2017
- Completion date
- January 6, 2022
- Enrollment
- 401 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
lumbosacral radicular pain